Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Immunoprecise Antibodies Ltd (NQ: IPA ) 0.4300 +0.0100 (+2.38%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Immunoprecise Antibodies Ltd < Previous 1 2 3 4 Next > ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation Today 8:01 EST From ImmunoPrecise Antibodies Ltd. Via Business Wire ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI Technology October 28, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024 October 21, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire ImmunoPrecise Antibodies Celebrates Nobel Prize in Chemistry, Advances in AI-Powered Protein Design October 10, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire ImmunoPrecise Subsidiary Signs Material Transfer Agreement with Biotheus October 02, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire ImmunoPrecise Antibodies Advances Therapeutic Innovation with Groundbreaking Rabbit Antibody Developments September 26, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025 September 16, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025 on September 16, 2024 September 09, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire ImmunoPrecise Antibodies to Participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York August 26, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire ImmunoPrecise Antibodies Receives Nasdaq Notification Regarding Minimum Bid Requirements August 23, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire ImmunoPrecise Antibodies (IPA) Reports Financial Results and Business Updates for Fourth Quarter and Full Fiscal Year 2024 July 29, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire ImmunoPrecise Antibodies to Reschedule Financial Results and Recent Business Highlights Report for Fourth Quarter and Fiscal Year-End 2024 July 23, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire ImmunoPrecise Announces Financing Agreement with Yorkville Advisors Global, LP of up to $3.0 Million Aggregate Principal Amount of Convertible Debentures July 16, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire IPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Fiscal Year End 2024 on July 25th, 2024 July 15, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire ImmunoPrecise Appoints Kristin Taylor as Chief Financial Officer June 27, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire IPA’s Subsidiary BioStrand and PGxAI Announce Strategic Collaboration to Develop First-In-Class AI Model for Pharmacogenomics Recommendations Using LENSai™ June 25, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire ImmunoPrecise Antibodies Ltd. Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSai™ Technology June 12, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire BioStrand, ImmunoPrecise Antibodies’ Subsidiary, Announces Immediate Commercial Offering of Groundbreaking Software with Customizable Interface for AI-Driven Drug Discovery June 10, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire IPA’s Subsidiary, BioStrand, Announces Advanced Large Language Model (LLM) for Electronic Health Records (EHR) June 04, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire Epitope Binning Powered By LENSai TM Technology Can Analyze Over 5,000 Sequences With No Physical Materials Needed, Matches Classical Wet Lab Binning Results April 22, 2024 Via ACCESSWIRE ImmunoPrecise Antibodies And InterSystems Partner To Leverage AI In Life Sciences, Transforming Patient Care With Accelerated Discovery And Delivery Of Treatments April 12, 2024 Via ACCESSWIRE InterSystems and IPA’s Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with LENSai for AI-Driven Healthcare Applications March 28, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire IPA Acquires the Carterra LSA® Instrument to Enhance Antibody Discovery and Bolster Its AI Developments March 20, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024* March 14, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire ImmunoPrecise Antibodies (NASDAQ:IPA) Subsidiary BioStrand Introduces Breakthrough AI Model In Life Sciences, Harnessing LLM Stacking And HYFT Technology March 08, 2024 Via ACCESSWIRE IPA’s subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT Technology March 07, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024 on March 14, 2024 March 04, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire ImmunoPrecise Antibodies (NASDAQ:IPA) Is Changing How We Look At The Complex World Of Antibody Discovery February 13, 2024 Via ACCESSWIRE ImmunoPrecise Antibodies Reports A 19.9% Revenue Increase As It Launches The Next Phase Of LENSai Portal And SaaS Platforms January 10, 2024 Via ACCESSWIRE IPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2024* December 14, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
